Providence to Expand Access to In-home, Outpatient PT with Luna

Luna, the leading provider of in-home physical therapy, today announced that Providence, a not-for-profit health system serving the Western U.S., will expand access to outpatient physical therapy service through the Luna technology platform.

The Luna technology platform will match eligible Providence patients to therapists based on factors, including specialty, geography, and schedules. Luna’s broad network of local physical therapists will provide consistent, high-quality care, of the type administered in a traditional outpatient clinic, but from the comfort of a patient’s home.

“Providence is an innovative health system that is continuously finding ways to meet patients where they are,” said Prasanna Mohanty, chief operating officer for the clinical network at Providence. “We recognize that there is a growing number of physical therapy outpatients needing or wanting to remain at home, and Luna’s in-home model will enable our teams to accommodate patient needs and ensure quality care that is safe and convenient.”

The platform will allow patients and therapists to communicate with each other and discuss care needs between visits. The same therapist will treat the patient for the entirety of the treatment plan, which will ensure consistent and quality care. Between visits, patients will use the Luna platform to communicate with their physical therapists, set appointment times, and perform therapist-prescribed and monitored exercises.

Providence

“Patients demand greater flexibility in outpatient services, including the ability to choose when and where services are performed,” said Palak Shah, co-founder and head of clinical operations at Luna. “The addition of Luna’s in-home physical therapy provides relief for health systems operating at capacity and needing more access. This will allow more patients within the Providence health system to complete their treatment plan at a convenient place and time — and ensure quality and continuity of care.”

Luna will accept all insurance providers contracted with Providence, with the exception of worker’s compensation and disability.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.